Notarangelo L D, Chirico G, Chiara A, Colombo A, Rondini G, Plebani A, Martini A, Ugazio A G
Pediatr Res. 1984 Mar;18(3):281-5. doi: 10.1203/00006450-198403000-00014.
Complement activity was compared in 50 low birth weight infants divided into appropriate and small for gestational age groups; the influence of birth weight and gestational age on complement development was also investigated. CH50 and kinetics (tH50) of both classical and alternative pathway activity of complement, C3, and Factor B levels were significantly higher in small for gestational age infants (classical pathway CH50, 630 HU/ml +/- 184 SD; CP tH50, 77 min +/- 47; aternative pathway CH50, 44.8 HU/ml +/- 11.3; AP tH50, 56 min +/- 43; C3, 73.98 mg/dl +/- 12.68; and Factor B, 13.17 mg/dl +/- 3.67) than in weight-matched appropriate for gestational age infants (CP CH50, 523 HU/ml +/- 152; CP tH50, 105 min +/- 49; AP CH50, 38.8 HU/ml +/- 13; AP tH50, 90 min +/- 53; C3, 58.14 mg/dl +/- 9.43; and Factor B, 9.32 mg/dl +/- 1.73). Complement values were lower in low birth weight infants than in adult controls (P less than 0.001 in all cases). All complement parameters were mainly correlated with gestational age; CH50 values of the classical and alternative pathways were also highly correlated with each other (r = 0.64; P less than 0.001). Low birth weight infants, especially preterm infants, have an important defect of complement activity. Complement factors increase gradually during gestation and intrauterine growth retardation does not affect complement development. Classical and alternative complement pathway activities have a similar development pattern.
对50名低出生体重婴儿进行了补体活性比较,这些婴儿被分为适于胎龄组和小于胎龄组;同时还研究了出生体重和胎龄对补体发育的影响。小于胎龄婴儿的补体经典途径和替代途径活性的CH50及动力学(tH50)、C3和B因子水平显著高于体重匹配的适于胎龄婴儿(经典途径CH50,630HU/ml±184标准差;CP tH50,77分钟±47;替代途径CH50,44.8HU/ml±11.3;AP tH50,56分钟±43;C3,73.98mg/dl±12.68;B因子,13.17mg/dl±3.67)(经典途径CH50,523HU/ml±152;CP tH50,105分钟±49;AP CH50,38.8HU/ml±13;AP tH50,90分钟±53;C3,58.14mg/dl±9.4;B因子,9.32mg/dl±1.73)。低出生体重婴儿的补体值低于成人对照组(所有情况P均小于0.001)。所有补体参数主要与胎龄相关;经典途径和替代途径的CH50值也高度相关(r=0.64;P小于0.0)。低出生体重婴儿,尤其是早产儿,存在补体活性的重要缺陷。补体因子在孕期逐渐增加,宫内生长迟缓不影响补体发育。经典和替代补体途径活性具有相似的发育模式。